BTT-3033
BTT-3033 is an orally active and potent α2β1 (EC50: 130 nM) inhibitor with an affinity for the α2I domain, inhibiting platelet binding to collagen I and cell proliferation. BTT-3033 induces apoptosis and can be used to study prostate cancer, inflammation, and cardiovascular disease.
Product Specifications
CAS Number
1259028-99-3
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
465.5
Molecular Formula
C23H20FN5O3S
Notes
Research use only, not for human use.
Receptor
Apoptosis | Integrin
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
24094061 1.0 µg DNA
HTRA3 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)
Sign In for Pricing
View Details 
QP10023-iv-10ug 10ug
Recombinant Human Thioredoxin-interacting protein Protein, His-SUMO, Invitro-E.coli-10ug
Sign In for Pricing
View Details abx336405-01 20 µg
Low Density Lipoprotein Receptor Related Protein 2 (LRP2) Antibody (HRP)
Sign In for Pricing
View Details 
abx336405-02 50 µg
Low Density Lipoprotein Receptor Related Protein 2 (LRP2) Antibody (HRP)
Sign In for Pricing
View Details